Understanding Different Stakeholders’ Priorities for an Independent Panel on Evidence for Action on AMR
Antimicrobial resistance (AMR) is a global threat requiring coordinated action. A global consultation process involving 60 experts and stakeholders reveals key considerations for an Independent Panel on Evidence for Action against AMR. Key considerations include equitable representation, scientific legitimacy, sustained funding, and practical mechanisms for evidence translation into action. The panel must be context-sensitive and responsive.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!
